top of page

Selected for the second round of research and development grants for fiscal year 2025 from the Mitsubishi UFJ Technology Development Foundation.

  • Feb 14
  • 1 min read


We have been selected for the "2025 Second Round Research and Development Grant" by the Mitsubishi UFJ Technology Development Foundation, which targets research and development of new technologies and products conducted by venture companies and other organizations.

Taking this as an opportunity, we will promote the development of angiogenesis therapy using ICS for critical lower limb ischemia .


 
 
 

Comments


Latest Articles
archive
Cellfold Co., Ltd.

© 2025 by CellFold, Inc.

bottom of page